Search research articles
Contact Us
Filters
Showing results (501-510 of 561) with videos related to
Page
of 57
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2025
Likelihood of blood culture positivity using SeptiCyte RAPID
Krupa Navalkar, Alyse Wheelock, Melissa Gregory, et al.
Cancer Medicine
|
November 21, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer
Daniel H Kwon, Lauren Trihy, Nika Darvish, et al.
Cancer
|
March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer
Daniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology
|
November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers
Daniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.
Cancer Research Communications
|
June 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, et al.
Journal of the American College of Cardiology
|
November 5, 2021
Socioeconomic Determinants of Health and Cardiovascular Outcomes in Women: JACC Review Topic of the Week
Kathryn J Lindley, Niti R Aggarwal, Joan E Briller, et al.
Lancet Regional Health. Americas
|
March 19, 2024
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
Neil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Cancer Immunology Research
|
January 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer
Hewitt Chang, Jaqueline Marquez, Brandon K Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 31, 2012
Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase
Franco R D'Alessio, Kenji Tsushima, Neil R Aggarwal, et al.
Page
of 57
Search research articles
Search
Showing results (501-510 of 561) with videos related to
Sort By:
Page
of 57
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2025
Likelihood of blood culture positivity using SeptiCyte RAPID
Krupa Navalkar, Alyse Wheelock, Melissa Gregory, et al.
Cancer Medicine
|
November 21, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer
Daniel H Kwon, Lauren Trihy, Nika Darvish, et al.
Cancer
|
March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer
Daniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology
|
November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers
Daniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.
Cancer Research Communications
|
June 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, et al.
Journal of the American College of Cardiology
|
November 5, 2021
Socioeconomic Determinants of Health and Cardiovascular Outcomes in Women: JACC Review Topic of the Week
Kathryn J Lindley, Niti R Aggarwal, Joan E Briller, et al.
Lancet Regional Health. Americas
|
March 19, 2024
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
Neil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Cancer Immunology Research
|
January 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer
Hewitt Chang, Jaqueline Marquez, Brandon K Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 31, 2012
Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase
Franco R D'Alessio, Kenji Tsushima, Neil R Aggarwal, et al.
Page
of 57